FINANCIAL STATEMENTS Notes to the Company Financial Statements Continued 58.
Net income for the year Hikma Pharmaceuticals PLC currently has sixteen employees 2014: sixteen excluding Executive Directors : total compensation paid to As permitted by section 408 of the Companies Act 2006, the statement of comprehensive income of the Company is not presented as part them amounted to $4 million 2014: $4 million of which salaries and wages compromise an amount of $3 million 2014: $3 million of these accounts.
The net income in the Company for the year is $133 million 2014: $361 million.
the remaining balance of $1 million 2014: $1 million represents national insurance contributions, the cost of share-based payments and Included in the net income for the year is an amount of $202 million 2014: $398 million representing dividends received and $3 million other benefits.
2014: $2 million representing the current year charge of LTIPs and EIPs.
The remaining $12 million 2014: $6 million of the Groups stock options, LTIPs, MIPs and EIPs charge is recharged to subsidiary companies.
Stock options The details of the stock compensation scheme are provided in note 38.
As at 31 December 2015, the total number of options granted 66.
Related parties to employees of the Company under the stock compensation scheme during the life of the scheme was 2,560,000 2014: 2,560,000 and Darhold Limited: is a related party of the Group because it is considered one of the major shareholders of Hikma Pharmaceuticals PLC the total amount of compensation expenses charged to profit or loss is $nil 2014: $nil.
with an ownership percentage of 29.06% at end of 2015 2014: 28.8%.
Further details on the relationship between, Mr Said Darwazah, Mr Mazen Darwazah and Mr Ali Al-Husry, and Darhold Limited are given in the Directors Report.
Long-term incentive plans Other than dividends as paid to all shareholders, there were no transactions between the Group and Darhold Limited during the period The details of the LTIP scheme are provided in note 38.
As at 31 December 2015, the total number of awards granted to employees of the Arab Bank: is a related party of the Company because one Hikma Pharmaceuticals PLC senior management member is also a board Company under the LTIPs during the life of the plans was 1,649,615 shares 2014:1,649,615 and the total amount of the compensation member of Arab Bank PLC.
Total cash balances at Arab Bank were $5.1 million 31 December 2014: $47.6 million.
Utilisation of facilities expenses charged to profit and loss is $2 million 2014: $2 million.
granted by Arab Bank to the Company amounted to $nil 31 December 2014: $ 37.4 million.
Interest expense income is within market rate.
Amounts repayable to and from subsidiaries are disclosed in Notes 49 and 54.
Management incentive plans The details of the MIP scheme are provided in note 38.
As at 31 December 2015, the total number of awards granted to employees of the Other transactions with related parties include management charges for services provided to the subsidiary companies, equity settled Company under the MIP during the life of the plans was 18,383 shares 2014:15,834 shares and the total amount of the compensation employee share scheme costs relating to the subsidiary companies and transactions with key management personnel.
Compensation paid to expenses charged to profit and loss is $nil 2014: $nil.
key management personnel is disclosed in Note 40.
Details of Directors remuneration are disclosed in the Remuneration Committee Report on pages 102 to 124.
Executive incentive plans The 2014 Executive Incentive Plan EIP was approved by shareholders at the 2014 Annual General Meeting.
The details of the EIP scheme More details on the general information of the ultimate parent of the Group are disclosed in Note 2. are provided in note 38.
As at 31 December 2015, the total number of awards granted to employees of the Company under the EIP during the life of the plans was 153,209 shares and the total amount of the compensation expenses charged to profit and loss is $1 million.
Contingent liabilities A contingent liability existed at the balance sheet date in respect of Standby Letter of Credit totalling to $9 million 2014: $nil.
Share capital 2015 2014 Issued and fully paid included in shareholders equity: $m $m 199,421,287 2014: 198,632,039 Ordinary Shares of 10p each 35 35 Details of the issue of share capital in the year are given in Note 33.
Share premium Share premium $m Balance at 1 January 2015 281 Premium arising on exercise of stock options 1 Balance at 31 December 2015 282 188 189 189
